The newly launched “What Science Can Do” campaign, a longstanding tagline for AstraZeneca, centers around the stories of two patients who have benefitted from the company’s therapeutics. Each of their ...

Linde India: The Supreme Court rejected Linde India's appeal against a Securities and Exchange Board of India (SEBI) ...

Among patients with limited-stage small cell lung cancer, the benefits of consolidation Imfinzi were seen across a number of ...

AstraZeneca Pharma India has received approval from the CDSO for the import, sale, and distribution of Durvalumab.

AstraZeneca topped the analyst consensus for net revenue and matched the analyst consensus for core EPS in Q2. See why I ...

Astrazeneca Pharma India has received CDSO's (Central Drugs Standard Control Organisation) nod for the import of Durvalumab ...

Reliance Power, Vodafone Idea, SpiceJet, NHPC, PNB - Stocks to Watch: Tuesday,4, 2024 Markets in India are poised for a ...

This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.

The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages ...

Indian shares were flat to slightly higher on Tuesday, with metal, oil/gas and power stocks pacing the gainers. The benchmark ...

The company has received approval to import, sell, and distribute Durvalumab Solution for infusion (Imfinzi) from the Central ...

Billionaire investor George Soros became nearly a household name in the early 1990’s by shorting the British pound and making ...